How Much Did RxLive Raise?
Funding & Key Investors

RxLive, a telehealth platform focused on clinical pharmacy services, has secured significant enterprise-level funding, with its total funding reaching $6.9M. The company recently announced a major strategic investment of $5M, underscoring its growth trajectory and market potential in the digital health sector. This latest capital infusion is expected to accelerate RxLive's expansion and enhance its service offerings.

What is RxLive?

RxLive
SoftwareHealthcare SoftwareHealthcare Services

Founded in 2017 and based in St. Petersburg, Florida, RxLive operates a telehealth platform designed to connect patients with highly trained clinical pharmacists. The service facilitates in-depth discussions about medications, ensuring patients receive the right drug at the right time and at the right price. RxLive collaborates with providers, employers, and clinical labs, as well as directly with consumers, to optimize medication management and improve health outcomes. The company's focus on accessible and personalized pharmaceutical care positions it as a key player in the evolving healthcare landscape.

How much funding has RxLive raised?

RxLive has raised a total of $6.9M across 3 funding rounds:

2021

Other Financing Round

$500K

Debt

$1.4M

2022

Series A

$5M

Other Financing Round (2021): $500K with participation from Seedfunders

Debt (2021): $1.4M, investors not publicly disclosed

Series A (2022): $5M supported by Springtide Capital and Cardinal Health

Key Investors in RxLive

Seedfunders

Seedfunders is an angel investing organization that supports early-stage startups, particularly those in Florida with a focus on scalable technology models. They provide funding, mentorship, and guidance to help companies grow.

Springtide Capital

Springtide Capital is a UK-based mortgage broker offering expert advice and access to a wide range of lenders for residential and buy-to-let mortgages. They specialize in tailored mortgage solutions and related insurance products.

What's next for RxLive?

With its recent major strategic investment, RxLive is poised for significant scaling and further development of its telehealth capabilities. The company's ability to secure substantial backing indicates strong investor confidence in its business model and its potential to disrupt traditional pharmacy services. Future initiatives will likely focus on expanding its network of clinical pharmacists, enhancing its technology platform for broader reach, and forging new partnerships within the healthcare ecosystem. This strategic financing will be instrumental in driving RxLive's mission to improve medication adherence and patient outcomes nationwide.

See full RxLive company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Software industry

Multimedia, Games & Graphics SoftwareSoftware
Enterprise Resource Planning (ERP)SoftwareContent & Collaboration Software
Healthcare SoftwareSoftwareHealthcare ServicesMental Health & Rehabilitation FacilitiesMobile App Development
Healthcare SoftwareSoftwareMobile App Development

Frequently Asked Questions Regarding RxLive Financial Insights

What are the most recent funding rounds that RxLive has completed, and what were the funding rounds?
RxLive has recently completed 3 funding rounds: Series A on Jul 26, 2022, Other Financing Round on May 3, 2021, Debt on May 3, 2021.
What is the total amount of funding RxLive has raised to date?
RxLive has raised a total of $6.9M in funding to date.
How many funding rounds has RxLive completed?
RxLive has completed 3 funding rounds.
How much funding did RxLive raise in its most recent funding round?
RxLive raised $5M in its most recent funding round.
Who are the lead investors in RxLive's latest funding round?
The lead investor in RxLive's latest funding round was Springtide Capital. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in RxLive's history?
The largest funding round in RxLive's history was $5M.
See more information about RxLive